rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-9-6
|
pubmed:abstractText |
To the authors' knowledge, little is known regarding the alterations of G(1)-S checkpoint and their significance in chordoma, a rare bone tumor. The authors investigated the clinicopathologic relevance of cell cycle abnormalities in chordoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1255-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16078265-Adolescent,
pubmed-meshheading:16078265-Adult,
pubmed-meshheading:16078265-Aged,
pubmed-meshheading:16078265-Aged, 80 and over,
pubmed-meshheading:16078265-Bone Neoplasms,
pubmed-meshheading:16078265-Child,
pubmed-meshheading:16078265-Chordoma,
pubmed-meshheading:16078265-Cyclin D1,
pubmed-meshheading:16078265-G1 Phase,
pubmed-meshheading:16078265-Humans,
pubmed-meshheading:16078265-Middle Aged,
pubmed-meshheading:16078265-Nuclear Proteins,
pubmed-meshheading:16078265-Prognosis,
pubmed-meshheading:16078265-Proto-Oncogene Proteins,
pubmed-meshheading:16078265-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:16078265-Retinoblastoma Protein,
pubmed-meshheading:16078265-S Phase,
pubmed-meshheading:16078265-Tumor Suppressor Protein p53
|
pubmed:year |
2005
|
pubmed:articleTitle |
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
|
pubmed:affiliation |
Department of Pathology, Faculty of Medicine, Otto-von-Guericke University Magdeburg, Germany. takahicom@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|